Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitochondrial DNA injury in PBMCs during adefovir or entecavir treatment
ChiCTR-TNRC-11001415Phase 4Completed
- Sponsor
- Science and Technology Committee
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of adefovir dipivoxil and entecavir in Chronic Hepatitis B (CHB) (2 arms), sponsored by Science and Technology Committee. Primary endpoint: Mitochondrial DNA content of peripheral blood mononuclear cells. Started Jul 2007; status: completed.
02
Drugs
adefovir dipivoxilentecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TNRC-11001415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-11001415.